These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 12357696

  • 1. [A new treatment for rheumatoid arthritis].
    Vervaeren J.
    J Pharm Belg; 2002; 57(4):82-8. PubMed ID: 12357696
    [No Abstract] [Full Text] [Related]

  • 2. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E, Wipff J, Avouac J, Kahan A, Allanore Y.
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract] [Full Text] [Related]

  • 3. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
    Blank N, Max R, Schiller M, Briem S, Lorenz HM.
    Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
    [No Abstract] [Full Text] [Related]

  • 4. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.
    Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T, Nara H, Iwamoto M, Yoshio T, Okazaki H, Minota S.
    J Rheumatol; 2008 May; 35(5):936-8. PubMed ID: 18464318
    [No Abstract] [Full Text] [Related]

  • 5. Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed?
    Yazici Y, Erkan D.
    Ann Rheum Dis; 2004 May; 63(5):607-8; author reply 608. PubMed ID: 15082503
    [No Abstract] [Full Text] [Related]

  • 6. The role of tumor necrosis factor inhibitors in patients with RA.
    Trethewey P.
    JAAPA; 2002 Sep; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668
    [No Abstract] [Full Text] [Related]

  • 7. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
    Kaplan MJ.
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633
    [No Abstract] [Full Text] [Related]

  • 8. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
    Lourari S, Prey S, Livideanu C, Jamard B, Lamant L, Cantagrel A, Paul C.
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
    [No Abstract] [Full Text] [Related]

  • 9. Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy.
    Gómez-Puerta JA, Sanmartí R, Rodríguez-Cros JR, Cañete JD.
    Ann Rheum Dis; 2004 Jul; 63(7):896. PubMed ID: 15194598
    [No Abstract] [Full Text] [Related]

  • 10. Anti-tumour necrosis factor therapy in the West Midlands.
    Bartram D, Sheeran T, Price T, Mulherin D.
    Rheumatology (Oxford); 2004 Mar; 43(3):400; author reply 400-1. PubMed ID: 14963219
    [No Abstract] [Full Text] [Related]

  • 11. Anti-tumour necrosis factor therapy for severe inflammatory arthritis: two years of experience in Northern Ireland.
    Cairns AP, Taggart AJ.
    Ulster Med J; 2002 Nov; 71(2):101-5. PubMed ID: 12513005
    [Abstract] [Full Text] [Related]

  • 12. Rheumatoid arthritis drugs show promise.
    Mayo Clin Health Lett; 1999 Jan; 17(1):4. PubMed ID: 9919935
    [No Abstract] [Full Text] [Related]

  • 13. [Etanercept].
    Mühlhäuser U, Münzel F, Eschenhagen T.
    Dtsch Med Wochenschr; 2003 Aug 22; 128(34-35):1775-8. PubMed ID: 12934172
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Patients receiving etanercept may develop antibodies that interfere with monoclonal antibody laboratory assays.
    Russell E, Zeihen M, Wergin S, Litton T.
    Arthritis Rheum; 2000 Apr 22; 43(4):944. PubMed ID: 10765944
    [No Abstract] [Full Text] [Related]

  • 16. Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors.
    Mizutani W.
    Manag Care Interface; 2003 Mar 22; 16(3):44-50, 55. PubMed ID: 12715413
    [Abstract] [Full Text] [Related]

  • 17. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.
    Malesci D, La Montagna G.
    Rheumatology (Oxford); 2008 May 22; 47(5):734-5. PubMed ID: 18326535
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.